US Patent Issued to Eleusis Therapeutics US on Feb. 10 for "Pharmaceutically acceptable salts of psilocin and uses thereof" (American, British Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,642, issued on Feb. 10, was assigned to Eleusis Therapeutics US Inc. (New York).

"Pharmaceutically acceptable salts of psilocin and uses thereof" was invented by David E. Nichols (Chapel Hill, N.C.), Graham Johnson (Sanbornton, N.H.), Hooshang S. Zavareh (Cambridge, Great Britain), Claire Wombwell (Cambridge, Great Britain), Daniel Rixson (Cambridge, Great Britain), Peter Haddow (Cambridge, Great Britain), Carrie Sheard (Cambridge, Great Britain) and Alexander Schwarz (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmac...